Identification and proteomic profiling of exosomes in human cerebrospinal fluid
Background Exosomes are released from multiple cell types, contain protein and RNA species, and have been exploited as a novel reservoir for disease biomarker discovery. They can transfer information between cells and may cause pathology, for example, a role for exosomes has been proposed in the pat...
Uložené v:
| Vydané v: | Journal of translational medicine Ročník 10; číslo 1; s. 5 |
|---|---|
| Hlavní autori: | , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
London
BioMed Central
05.01.2012
BioMed Central Ltd Springer Nature B.V BMC |
| Predmet: | |
| ISSN: | 1479-5876, 1479-5876 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Background
Exosomes are released from multiple cell types, contain protein and RNA species, and have been exploited as a novel reservoir for disease biomarker discovery. They can transfer information between cells and may cause pathology, for example, a role for exosomes has been proposed in the pathophysiology of Alzheimer's disease. Although studied in several biofluids, exosomes have not been extensively studied in the cerebrospinal fluid (CSF) from humans. The objective of this study was to determine: 1) whether human CSF contains exosomes and 2) the variability in exosomal protein content across individuals.
Methods
CSF was collected from 5 study participants undergoing thoraco-abdominal aortic aneurysm repair (around 200 - 500 ml per participant) and low-density membrane vesicles were concentrated by ultracentrifugation. The presence of exosomes was determined by western blot for marker proteins, isopycnic centrifugation on a sucrose step gradient and transmission electron microscopy with immuno-labelling. Whole protein profiling was performed using Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR).
Results
Flotillin 1 and tumor susceptibility gene 101 (TSG101), two exosomal marker proteins, were identified in the ultracentrifugation pellet using western blot. These markers localized to a density consistent with exosomes following isopycnic centrifugation. Transmission electron microscopy visualized structures consistent with exosomes in size and appearance that labelled positive for flotillin 1. Therefore, the pellet that resulted from ultracentrifugation of human CSF contained exosomes. FT-ICR profiling of this pellet was performed and 84-161 ions were detected per study participant. Around one third of these ions were only present in a single study participant and one third were detected in all five. With regard to ion quantity, the median coefficient of variation was 81% for ions detected in two or more samples.
Conclusions
Exosomes were identified in human CSF and their proteome is a potential new reservoir for biomarker discovery in neurological disorders such as Alzheimer's disease. However, techniques used to concentrate exosomes from CSF need refinement to reduce variability. In this study we used relatively large starting volumes of human CSF, future studies will focus on exosome isolation from smaller 'real life' clinical samples; a key challenge in the development of exosomes as translational tools. |
|---|---|
| AbstractList | Background
Exosomes are released from multiple cell types, contain protein and RNA species, and have been exploited as a novel reservoir for disease biomarker discovery. They can transfer information between cells and may cause pathology, for example, a role for exosomes has been proposed in the pathophysiology of Alzheimer's disease. Although studied in several biofluids, exosomes have not been extensively studied in the cerebrospinal fluid (CSF) from humans. The objective of this study was to determine: 1) whether human CSF contains exosomes and 2) the variability in exosomal protein content across individuals.
Methods
CSF was collected from 5 study participants undergoing thoraco-abdominal aortic aneurysm repair (around 200 - 500 ml per participant) and low-density membrane vesicles were concentrated by ultracentrifugation. The presence of exosomes was determined by western blot for marker proteins, isopycnic centrifugation on a sucrose step gradient and transmission electron microscopy with immuno-labelling. Whole protein profiling was performed using Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR).
Results
Flotillin 1 and tumor susceptibility gene 101 (TSG101), two exosomal marker proteins, were identified in the ultracentrifugation pellet using western blot. These markers localized to a density consistent with exosomes following isopycnic centrifugation. Transmission electron microscopy visualized structures consistent with exosomes in size and appearance that labelled positive for flotillin 1. Therefore, the pellet that resulted from ultracentrifugation of human CSF contained exosomes. FT-ICR profiling of this pellet was performed and 84-161 ions were detected per study participant. Around one third of these ions were only present in a single study participant and one third were detected in all five. With regard to ion quantity, the median coefficient of variation was 81% for ions detected in two or more samples.
Conclusions
Exosomes were identified in human CSF and their proteome is a potential new reservoir for biomarker discovery in neurological disorders such as Alzheimer's disease. However, techniques used to concentrate exosomes from CSF need refinement to reduce variability. In this study we used relatively large starting volumes of human CSF, future studies will focus on exosome isolation from smaller 'real life' clinical samples; a key challenge in the development of exosomes as translational tools. Abstract Background: Exosomes are released from multiple cell types, contain protein and RNA species, and have been exploited as a novel reservoir for disease biomarker discovery. They can transfer information between cells and may cause pathology, for example, a role for exosomes has been proposed in the pathophysiology of Alzheimer's disease. Although studied in several biofluids, exosomes have not been extensively studied in the cerebrospinal fluid (CSF) from humans. The objective of this study was to determine: 1) whether human CSF contains exosomes and 2) the variability in exosomal protein content across individuals. Methods: CSF was collected from 5 study participants undergoing thoraco-abdominal aortic aneurysm repair (around 200 - 500 ml per participant) and low-density membrane vesicles were concentrated by ultracentrifugation. The presence of exosomes was determined by western blot for marker proteins, isopycnic centrifugation on a sucrose step gradient and transmission electron microscopy with immuno-labelling. Whole protein profiling was performed using Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR). Results: Flotillin 1 and tumor susceptibility gene 101 (TSG101), two exosomal marker proteins, were identified in the ultracentrifugation pellet using western blot. These markers localized to a density consistent with exosomes following isopycnic centrifugation. Transmission electron microscopy visualized structures consistent with exosomes in size and appearance that labelled positive for flotillin 1. Therefore, the pellet that resulted from ultracentrifugation of human CSF contained exosomes. FT-ICR profiling of this pellet was performed and 84-161 ions were detected per study participant. Around one third of these ions were only present in a single study participant and one third were detected in all five. With regard to ion quantity, the median coefficient of variation was 81% for ions detected in two or more samples. Conclusions: Exosomes were identified in human CSF and their proteome is a potential new reservoir for biomarker discovery in neurological disorders such as Alzheimer's disease. However, techniques used to concentrate exosomes from CSF need refinement to reduce variability. In this study we used relatively large starting volumes of human CSF, future studies will focus on exosome isolation from smaller 'real life' clinical samples; a key challenge in the development of exosomes as translational tools. Exosomes are released from multiple cell types, contain protein and RNA species, and have been exploited as a novel reservoir for disease biomarker discovery. They can transfer information between cells and may cause pathology, for example, a role for exosomes has been proposed in the pathophysiology of Alzheimer's disease. Although studied in several biofluids, exosomes have not been extensively studied in the cerebrospinal fluid (CSF) from humans. The objective of this study was to determine: 1) whether human CSF contains exosomes and 2) the variability in exosomal protein content across individuals.BACKGROUNDExosomes are released from multiple cell types, contain protein and RNA species, and have been exploited as a novel reservoir for disease biomarker discovery. They can transfer information between cells and may cause pathology, for example, a role for exosomes has been proposed in the pathophysiology of Alzheimer's disease. Although studied in several biofluids, exosomes have not been extensively studied in the cerebrospinal fluid (CSF) from humans. The objective of this study was to determine: 1) whether human CSF contains exosomes and 2) the variability in exosomal protein content across individuals.CSF was collected from 5 study participants undergoing thoraco-abdominal aortic aneurysm repair (around 200 - 500 ml per participant) and low-density membrane vesicles were concentrated by ultracentrifugation. The presence of exosomes was determined by western blot for marker proteins, isopycnic centrifugation on a sucrose step gradient and transmission electron microscopy with immuno-labelling. Whole protein profiling was performed using Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR).METHODSCSF was collected from 5 study participants undergoing thoraco-abdominal aortic aneurysm repair (around 200 - 500 ml per participant) and low-density membrane vesicles were concentrated by ultracentrifugation. The presence of exosomes was determined by western blot for marker proteins, isopycnic centrifugation on a sucrose step gradient and transmission electron microscopy with immuno-labelling. Whole protein profiling was performed using Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR).Flotillin 1 and tumor susceptibility gene 101 (TSG101), two exosomal marker proteins, were identified in the ultracentrifugation pellet using western blot. These markers localized to a density consistent with exosomes following isopycnic centrifugation. Transmission electron microscopy visualized structures consistent with exosomes in size and appearance that labelled positive for flotillin 1. Therefore, the pellet that resulted from ultracentrifugation of human CSF contained exosomes. FT-ICR profiling of this pellet was performed and 84-161 ions were detected per study participant. Around one third of these ions were only present in a single study participant and one third were detected in all five. With regard to ion quantity, the median coefficient of variation was 81% for ions detected in two or more samples.RESULTSFlotillin 1 and tumor susceptibility gene 101 (TSG101), two exosomal marker proteins, were identified in the ultracentrifugation pellet using western blot. These markers localized to a density consistent with exosomes following isopycnic centrifugation. Transmission electron microscopy visualized structures consistent with exosomes in size and appearance that labelled positive for flotillin 1. Therefore, the pellet that resulted from ultracentrifugation of human CSF contained exosomes. FT-ICR profiling of this pellet was performed and 84-161 ions were detected per study participant. Around one third of these ions were only present in a single study participant and one third were detected in all five. With regard to ion quantity, the median coefficient of variation was 81% for ions detected in two or more samples.Exosomes were identified in human CSF and their proteome is a potential new reservoir for biomarker discovery in neurological disorders such as Alzheimer's disease. However, techniques used to concentrate exosomes from CSF need refinement to reduce variability. In this study we used relatively large starting volumes of human CSF, future studies will focus on exosome isolation from smaller 'real life' clinical samples; a key challenge in the development of exosomes as translational tools.CONCLUSIONSExosomes were identified in human CSF and their proteome is a potential new reservoir for biomarker discovery in neurological disorders such as Alzheimer's disease. However, techniques used to concentrate exosomes from CSF need refinement to reduce variability. In this study we used relatively large starting volumes of human CSF, future studies will focus on exosome isolation from smaller 'real life' clinical samples; a key challenge in the development of exosomes as translational tools. Exosomes are released from multiple cell types, contain protein and RNA species, and have been exploited as a novel reservoir for disease biomarker discovery. They can transfer information between cells and may cause pathology, for example, a role for exosomes has been proposed in the pathophysiology of Alzheimer's disease. Although studied in several biofluids, exosomes have not been extensively studied in the cerebrospinal fluid (CSF) from humans. The objective of this study was to determine: 1) whether human CSF contains exosomes and 2) the variability in exosomal protein content across individuals. CSF was collected from 5 study participants undergoing thoraco-abdominal aortic aneurysm repair (around 200 - 500 ml per participant) and low-density membrane vesicles were concentrated by ultracentrifugation. The presence of exosomes was determined by western blot for marker proteins, isopycnic centrifugation on a sucrose step gradient and transmission electron microscopy with immuno-labelling. Whole protein profiling was performed using Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR). Flotillin 1 and tumor susceptibility gene 101 (TSG101), two exosomal marker proteins, were identified in the ultracentrifugation pellet using western blot. These markers localized to a density consistent with exosomes following isopycnic centrifugation. Transmission electron microscopy visualized structures consistent with exosomes in size and appearance that labelled positive for flotillin 1. Therefore, the pellet that resulted from ultracentrifugation of human CSF contained exosomes. FT-ICR profiling of this pellet was performed and 84-161 ions were detected per study participant. Around one third of these ions were only present in a single study participant and one third were detected in all five. With regard to ion quantity, the median coefficient of variation was 81% for ions detected in two or more samples. Exosomes were identified in human CSF and their proteome is a potential new reservoir for biomarker discovery in neurological disorders such as Alzheimer's disease. However, techniques used to concentrate exosomes from CSF need refinement to reduce variability. In this study we used relatively large starting volumes of human CSF, future studies will focus on exosome isolation from smaller 'real life' clinical samples; a key challenge in the development of exosomes as translational tools. Exosomes are released from multiple cell types, contain protein and RNA species, and have been exploited as a novel reservoir for disease biomarker discovery. They can transfer information between cells and may cause pathology, for example, a role for exosomes has been proposed in the pathophysiology of Alzheimer's disease. Although studied in several biofluids, exosomes have not been extensively studied in the cerebrospinal fluid (CSF) from humans. The objective of this study was to determine: 1) whether human CSF contains exosomes and 2) the variability in exosomal protein content across individuals. CSF was collected from 5 study participants undergoing thoraco-abdominal aortic aneurysm repair (around 200 - 500 ml per participant) and low-density membrane vesicles were concentrated by ultracentrifugation. The presence of exosomes was determined by western blot for marker proteins, isopycnic centrifugation on a sucrose step gradient and transmission electron microscopy with immuno-labelling. Whole protein profiling was performed using Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR). Flotillin 1 and tumor susceptibility gene 101 (TSG101), two exosomal marker proteins, were identified in the ultracentrifugation pellet using western blot. These markers localized to a density consistent with exosomes following isopycnic centrifugation. Transmission electron microscopy visualized structures consistent with exosomes in size and appearance that labelled positive for flotillin 1. Therefore, the pellet that resulted from ultracentrifugation of human CSF contained exosomes. FT-ICR profiling of this pellet was performed and 84-161 ions were detected per study participant. Around one third of these ions were only present in a single study participant and one third were detected in all five. With regard to ion quantity, the median coefficient of variation was 81% for ions detected in two or more samples. Exosomes were identified in human CSF and their proteome is a potential new reservoir for biomarker discovery in neurological disorders such as Alzheimer's disease. However, techniques used to concentrate exosomes from CSF need refinement to reduce variability. In this study we used relatively large starting volumes of human CSF, future studies will focus on exosome isolation from smaller 'real life' clinical samples; a key challenge in the development of exosomes as translational tools. Background Exosomes are released from multiple cell types, contain protein and RNA species, and have been exploited as a novel reservoir for disease biomarker discovery. They can transfer information between cells and may cause pathology, for example, a role for exosomes has been proposed in the pathophysiology of Alzheimer's disease. Although studied in several biofluids, exosomes have not been extensively studied in the cerebrospinal fluid (CSF) from humans. The objective of this study was to determine: 1) whether human CSF contains exosomes and 2) the variability in exosomal protein content across individuals. Methods CSF was collected from 5 study participants undergoing thoraco-abdominal aortic aneurysm repair (around 200 - 500 ml per participant) and low-density membrane vesicles were concentrated by ultracentrifugation. The presence of exosomes was determined by western blot for marker proteins, isopycnic centrifugation on a sucrose step gradient and transmission electron microscopy with immuno-labelling. Whole protein profiling was performed using Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR). Results Flotillin 1 and tumor susceptibility gene 101 (TSG101), two exosomal marker proteins, were identified in the ultracentrifugation pellet using western blot. These markers localized to a density consistent with exosomes following isopycnic centrifugation. Transmission electron microscopy visualized structures consistent with exosomes in size and appearance that labelled positive for flotillin 1. Therefore, the pellet that resulted from ultracentrifugation of human CSF contained exosomes. FT-ICR profiling of this pellet was performed and 84-161 ions were detected per study participant. Around one third of these ions were only present in a single study participant and one third were detected in all five. With regard to ion quantity, the median coefficient of variation was 81% for ions detected in two or more samples. Conclusions Exosomes were identified in human CSF and their proteome is a potential new reservoir for biomarker discovery in neurological disorders such as Alzheimer's disease. However, techniques used to concentrate exosomes from CSF need refinement to reduce variability. In this study we used relatively large starting volumes of human CSF, future studies will focus on exosome isolation from smaller 'real life' clinical samples; a key challenge in the development of exosomes as translational tools. |
| ArticleNumber | 5 |
| Audience | Academic |
| Author | Chalmers, Rod TA Balmforth, Craig Webb, David J Weidt, Stefan Barran, Perdita E Mackay, C Logan Walsh, Tim S Street, Jonathan M Dear, James W |
| AuthorAffiliation | 4 Royal Infirmary of Edinburgh, Vascular Surgery Service, Edinburgh, UK 1 University/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK 3 Royal Infirmary of Edinburgh, Critical Care, Edinburgh, UK 2 EastChem School of Chemistry, The University of Edinburgh, Edinburgh, UK |
| AuthorAffiliation_xml | – name: 4 Royal Infirmary of Edinburgh, Vascular Surgery Service, Edinburgh, UK – name: 2 EastChem School of Chemistry, The University of Edinburgh, Edinburgh, UK – name: 1 University/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK – name: 3 Royal Infirmary of Edinburgh, Critical Care, Edinburgh, UK |
| Author_xml | – sequence: 1 givenname: Jonathan M surname: Street fullname: Street, Jonathan M organization: University/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute, The University of Edinburgh – sequence: 2 givenname: Perdita E surname: Barran fullname: Barran, Perdita E organization: EastChem School of Chemistry, The University of Edinburgh – sequence: 3 givenname: C Logan surname: Mackay fullname: Mackay, C Logan organization: EastChem School of Chemistry, The University of Edinburgh – sequence: 4 givenname: Stefan surname: Weidt fullname: Weidt, Stefan organization: EastChem School of Chemistry, The University of Edinburgh – sequence: 5 givenname: Craig surname: Balmforth fullname: Balmforth, Craig organization: University/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute, The University of Edinburgh – sequence: 6 givenname: Tim S surname: Walsh fullname: Walsh, Tim S organization: Royal Infirmary of Edinburgh, Critical Care – sequence: 7 givenname: Rod TA surname: Chalmers fullname: Chalmers, Rod TA organization: Royal Infirmary of Edinburgh, Vascular Surgery Service – sequence: 8 givenname: David J surname: Webb fullname: Webb, David J organization: University/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute, The University of Edinburgh – sequence: 9 givenname: James W surname: Dear fullname: Dear, James W email: james.dear@ed.ac.uk organization: University/British Heart Foundation Centre for Cardiovascular Science, Queen's Medical Research Institute, The University of Edinburgh |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22221959$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1Uk1v1DAUjFAR_YArRxTBgVNa2_FHfEGqKj5WqtQLnC3Hft66SuzFThD8e5zdsu1WNI4U63lmMn5vTqujEANU1VuMzjHu-AWmQjasE7zBqGEvqpN94ejR_rg6zfkOIUIZla-qY1IeLJk8qW5WFsLknTd68jHUOth6k-IEcfRm2Tk_-LCuo6vhd8xxhFz7UN_Oow61gQR9innjgx5qN8zevq5eOj1keHP_Pat-fPn8_epbc33zdXV1ed0YztjUCNELhIxDVoIVDlEnADTRFjNomebaig4Dpz0w0_UEJJdAKdatcIQxJ9uzarXTtVHfqU3yo05_VNRebQsxrZVOkzcDKI47S1wnNMOMthw0l7Q3prPMcaJbVrQ-7bQ2cz-CNaUhSQ8Hoocnwd-qdfylWiIY7VAR-HgvkOLPGfKkRp8NDIMOEOesJMGYIsEX2--fIO_inEr3FhAiEomtnw870FoX-z64WP5qFkl1SYSU5e1oQZ3_B1WWhTK6kpIyOTgkvHt8zf39_oXhQdGUmeYEbg_BSC1pU0ug1BKopbIYpU8Ixk_bHBUrfniedrGj5aIf1pAemvAM4y_hSOX5 |
| CitedBy_id | crossref_primary_10_3390_ijms24054577 crossref_primary_10_1007_s12015_023_10512_6 crossref_primary_10_1093_burnst_tkab043 crossref_primary_10_1096_fba_2020_00025 crossref_primary_10_1016_j_bbcan_2019_01_008 crossref_primary_10_3389_fimmu_2020_576516 crossref_primary_10_1016_j_neures_2019_10_010 crossref_primary_10_1177_17590914221087817 crossref_primary_10_3390_biomedicines12122834 crossref_primary_10_3390_ijms21072299 crossref_primary_10_3389_fonc_2020_602217 crossref_primary_10_3402_jev_v2i0_20424 crossref_primary_10_1146_annurev_physiol_021115_104929 crossref_primary_10_3390_cancers13030473 crossref_primary_10_3390_cells13090754 crossref_primary_10_1002_jcb_27813 crossref_primary_10_1186_s12964_014_0064_8 crossref_primary_10_1038_nrneph_2017_98 crossref_primary_10_1016_j_jconrel_2016_07_054 crossref_primary_10_1002_pmic_201200533 crossref_primary_10_1016_j_critrevonc_2024_104608 crossref_primary_10_1016_j_apsb_2021_03_012 crossref_primary_10_1038_s41416_023_02548_9 crossref_primary_10_1016_j_bcp_2017_12_020 crossref_primary_10_1016_j_nantod_2020_100964 crossref_primary_10_1002_prca_201400097 crossref_primary_10_1016_j_vesic_2025_100071 crossref_primary_10_1038_srep31172 crossref_primary_10_1155_2016_9852494 crossref_primary_10_1016_j_semcancer_2021_07_014 crossref_primary_10_3390_cells14060409 crossref_primary_10_1016_j_lfs_2021_119339 crossref_primary_10_1080_10408363_2020_1751584 crossref_primary_10_1016_j_bbcan_2020_188463 crossref_primary_10_1016_j_ymthe_2023_05_012 crossref_primary_10_1039_C5AN01648G crossref_primary_10_3390_ijms21031163 crossref_primary_10_1371_journal_pone_0110443 crossref_primary_10_1016_j_phrs_2020_105041 crossref_primary_10_1080_01635581_2019_1604978 crossref_primary_10_3389_fnins_2016_00127 crossref_primary_10_1515_cclm_2022_0793 crossref_primary_10_1002_cphc_201701198 crossref_primary_10_1007_s12035_023_03730_z crossref_primary_10_3390_ncrna4040030 crossref_primary_10_4103_NRR_NRR_D_24_00243 crossref_primary_10_3390_cancers12102745 crossref_primary_10_1186_s13046_018_0825_0 crossref_primary_10_1016_j_brainres_2018_03_034 crossref_primary_10_1134_S1068162020060357 crossref_primary_10_1007_s10930_019_09849_0 crossref_primary_10_1007_s12035_025_05040_y crossref_primary_10_1186_s12951_025_03527_3 crossref_primary_10_1111_cpr_12233 crossref_primary_10_1007_s10143_014_0539_5 crossref_primary_10_1097_QAD_0000000000002121 crossref_primary_10_1007_s00216_022_04178_1 crossref_primary_10_3390_cancers13020209 crossref_primary_10_3892_ijmm_2018_3383 crossref_primary_10_1016_j_carbpol_2018_08_141 crossref_primary_10_1186_s12907_015_0005_5 crossref_primary_10_1016_j_jmoldx_2016_08_007 crossref_primary_10_1016_j_jneuroim_2015_09_006 crossref_primary_10_1371_journal_pone_0158278 crossref_primary_10_1016_j_ymeth_2020_02_002 crossref_primary_10_3892_ol_2015_3841 crossref_primary_10_3390_metabo12010080 crossref_primary_10_3390_v14051083 crossref_primary_10_1002_biot_202200575 crossref_primary_10_1111_cns_14677 crossref_primary_10_3389_fphar_2023_1216149 crossref_primary_10_3389_fncel_2015_00501 crossref_primary_10_1016_j_semcancer_2014_04_010 crossref_primary_10_1038_srep44706 crossref_primary_10_1177_15353702231151960 crossref_primary_10_3390_biomedicines9030230 crossref_primary_10_3390_brainsci11020258 crossref_primary_10_1016_j_jprot_2017_01_019 crossref_primary_10_1186_1471_2164_14_319 crossref_primary_10_1016_j_achaem_2017_03_003 crossref_primary_10_1016_j_intimp_2020_106298 crossref_primary_10_2147_IJN_S502400 crossref_primary_10_1016_j_cellimm_2014_09_004 crossref_primary_10_1080_20013078_2017_1333882 crossref_primary_10_3390_ijms25031629 crossref_primary_10_1371_journal_pone_0237795 crossref_primary_10_1186_s12943_023_01741_x crossref_primary_10_1007_s40291_016_0220_5 crossref_primary_10_3390_cells10102622 crossref_primary_10_3389_fvets_2020_589117 crossref_primary_10_3390_cancers14235793 crossref_primary_10_3390_jpm10040221 crossref_primary_10_1111_cas_16341 crossref_primary_10_1002_jex2_70021 crossref_primary_10_1016_j_blre_2012_12_002 crossref_primary_10_1016_j_pneurobio_2018_06_006 crossref_primary_10_1186_s13195_019_0533_9 crossref_primary_10_1111_jnc_13036 crossref_primary_10_3389_fncel_2014_00100 crossref_primary_10_3389_fcell_2020_00483 crossref_primary_10_3390_biomedicines9060603 crossref_primary_10_1158_1078_0432_CCR_15_2965 crossref_primary_10_1016_j_biochi_2013_07_015 crossref_primary_10_1186_1742_2094_11_68 crossref_primary_10_1002_cam4_2873 crossref_primary_10_1007_s12035_017_0582_7 crossref_primary_10_3390_biom10060901 crossref_primary_10_1007_s40572_016_0093_0 crossref_primary_10_1002_glia_22772 crossref_primary_10_2217_BMM_15_45 crossref_primary_10_1186_s12645_023_00217_3 crossref_primary_10_3389_fcvm_2023_1090909 crossref_primary_10_1186_2001_1326_3_24 crossref_primary_10_1039_C4AN00627E crossref_primary_10_3390_ijms22157763 crossref_primary_10_1016_j_cmet_2018_05_001 crossref_primary_10_1097_JS9_0000000000002518 crossref_primary_10_1038_s41598_017_18672_5 crossref_primary_10_3390_ijms26146825 crossref_primary_10_1002_pmic_201800257 crossref_primary_10_1002_jat_3898 crossref_primary_10_1371_journal_pone_0113116 crossref_primary_10_3390_microorganisms7020048 crossref_primary_10_1038_mtna_2013_28 crossref_primary_10_1186_s13046_014_0086_5 crossref_primary_10_2460_ajvr_80_5_449 crossref_primary_10_1016_j_jbc_2022_102394 crossref_primary_10_3389_fgene_2018_00092 crossref_primary_10_3389_fphar_2022_878058 crossref_primary_10_1007_s12035_021_02705_2 crossref_primary_10_3389_fnins_2019_01059 crossref_primary_10_1016_j_tcb_2023_01_002 crossref_primary_10_1038_srep11295 crossref_primary_10_3390_biom15040587 crossref_primary_10_1093_bib_bbaa015 crossref_primary_10_4103_NRR_NRR_D_23_02051 crossref_primary_10_1002_jev2_12276 crossref_primary_10_1155_2018_6895464 crossref_primary_10_3389_fchem_2017_00102 crossref_primary_10_3390_cancers13061209 crossref_primary_10_1016_j_ijbiomac_2025_146563 crossref_primary_10_3390_ijms252413705 crossref_primary_10_1631_jzus_B1600490 crossref_primary_10_1016_j_conb_2013_09_004 crossref_primary_10_1097_JCMA_0000000000000899 crossref_primary_10_3389_fmicb_2021_785856 crossref_primary_10_3390_cancers13174397 crossref_primary_10_32604_or_2023_030401 crossref_primary_10_1016_j_jprot_2014_04_028 crossref_primary_10_1089_scd_2013_0594 crossref_primary_10_1016_j_snb_2019_126900 crossref_primary_10_3390_ncrna10030029 crossref_primary_10_3390_vaccines9080930 crossref_primary_10_1016_j_jprot_2015_01_017 crossref_primary_10_1016_j_addr_2012_06_011 crossref_primary_10_2217_bmm_2018_0034 crossref_primary_10_1080_08923973_2019_1650371 crossref_primary_10_3389_fcell_2021_793363 crossref_primary_10_1016_j_neulet_2016_10_042 crossref_primary_10_1186_s40035_024_00418_9 crossref_primary_10_1016_j_brainres_2014_09_070 crossref_primary_10_1016_j_cellsig_2020_109751 crossref_primary_10_1007_s13365_016_0436_5 crossref_primary_10_3389_fimmu_2024_1423232 crossref_primary_10_3892_ol_2019_10776 crossref_primary_10_1517_14712598_2015_977250 crossref_primary_10_1186_s13045_019_0739_0 crossref_primary_10_3390_microorganisms12020274 crossref_primary_10_3390_pharmaceutics12040372 crossref_primary_10_1039_C9NR03040A crossref_primary_10_3390_ncrna4020011 crossref_primary_10_1016_j_bbadis_2015_09_020 crossref_primary_10_1016_j_mam_2022_101167 crossref_primary_10_3389_fimmu_2023_1326836 crossref_primary_10_1093_neuonc_nou292 crossref_primary_10_1017_S1431927620000070 crossref_primary_10_1038_s41596_019_0126_x crossref_primary_10_3109_21678421_2014_905606 crossref_primary_10_3389_fphys_2017_00494 crossref_primary_10_3389_fimmu_2016_00500 crossref_primary_10_1186_s12987_017_0056_3 crossref_primary_10_1016_j_semcdb_2019_11_008 crossref_primary_10_1186_s40364_019_0156_0 crossref_primary_10_1016_j_ymeth_2015_04_015 crossref_primary_10_3389_fgene_2023_1091223 crossref_primary_10_1016_j_biocel_2018_04_009 crossref_primary_10_3389_fimmu_2021_792691 crossref_primary_10_1007_s12010_017_2478_4 crossref_primary_10_1016_j_fct_2016_06_010 crossref_primary_10_1109_ACCESS_2018_2828038 crossref_primary_10_3389_fphar_2016_00231 crossref_primary_10_1016_j_neurobiolaging_2018_10_006 crossref_primary_10_3390_ijms17020173 crossref_primary_10_1016_j_toxlet_2014_01_013 crossref_primary_10_1002_adbi_201700040 crossref_primary_10_3233_JAD_160639 crossref_primary_10_1016_j_neulet_2021_135914 crossref_primary_10_3390_jpm10020020 crossref_primary_10_3389_fncel_2015_00480 crossref_primary_10_1080_20013078_2018_1508271 crossref_primary_10_1371_journal_pone_0229602 crossref_primary_10_1016_j_matbio_2014_05_007 crossref_primary_10_1186_1757_2215_7_14 crossref_primary_10_1371_journal_pone_0200602 crossref_primary_10_3389_fneur_2015_00256 crossref_primary_10_1002_jbt_22462 crossref_primary_10_1038_s41531_023_00445_9 crossref_primary_10_18632_oncotarget_10807 crossref_primary_10_1016_j_ymben_2017_01_001 crossref_primary_10_1590_1984_3143_ar2025_0049 crossref_primary_10_1016_j_jim_2025_113877 crossref_primary_10_3390_bios12090704 crossref_primary_10_1186_s40478_017_0492_y crossref_primary_10_1038_s41598_020_59414_4 crossref_primary_10_1016_j_jim_2014_06_007 crossref_primary_10_1016_j_meegid_2017_05_021 crossref_primary_10_1007_s11060_015_1784_3 crossref_primary_10_3390_genes14071367 crossref_primary_10_3390_cells7100179 crossref_primary_10_1016_j_ijcard_2016_10_007 crossref_primary_10_1159_000527182 crossref_primary_10_1080_10408363_2018_1462759 crossref_primary_10_1002_adhm_202101658 crossref_primary_10_2217_bmm_2020_0022 crossref_primary_10_1002_advs_202103222 crossref_primary_10_1002_adbi_202101099 crossref_primary_10_1515_hsz_2016_0201 crossref_primary_10_3390_cells10061287 crossref_primary_10_1155_2015_152926 crossref_primary_10_1080_14686996_2022_2133342 crossref_primary_10_3402_jev_v5_29975 crossref_primary_10_1007_s10555_014_9547_8 crossref_primary_10_1080_23744235_2022_2149852 crossref_primary_10_1016_j_mam_2015_06_008 crossref_primary_10_1186_s12943_022_01509_9 crossref_primary_10_1371_journal_pone_0048814 crossref_primary_10_1016_j_omtm_2024_101259 crossref_primary_10_1186_s12943_017_0706_8 crossref_primary_10_1016_j_jconrel_2017_07_023 crossref_primary_10_1016_j_jconrel_2019_07_021 crossref_primary_10_1038_s41392_020_00258_9 crossref_primary_10_1042_BST20200788 crossref_primary_10_3390_biomedicines11041053 crossref_primary_10_1080_14737159_2019_1657407 crossref_primary_10_1080_15548627_2017_1395992 crossref_primary_10_3390_ijms26157559 crossref_primary_10_4103_0366_6999_232801 crossref_primary_10_3892_ol_2015_4044 crossref_primary_10_3390_proteomes7020022 crossref_primary_10_3109_01913123_2014_981327 crossref_primary_10_1016_j_bbrc_2016_09_069 crossref_primary_10_1016_j_neulet_2021_135829 crossref_primary_10_1038_s41467_019_11534_w crossref_primary_10_1002_mco2_660 crossref_primary_10_1016_j_bbagen_2015_05_016 crossref_primary_10_1523_JNEUROSCI_0147_18_2019 crossref_primary_10_1042_BST20160334 crossref_primary_10_1586_epr_12_70 crossref_primary_10_3390_ijms26125430 crossref_primary_10_1007_s00018_017_2664_0 crossref_primary_10_1002_jex2_55 crossref_primary_10_3402_jev_v2i0_20360 crossref_primary_10_1016_j_trac_2016_10_012 crossref_primary_10_3389_fnins_2022_936760 crossref_primary_10_3390_v7062770 crossref_primary_10_3390_ijms21228819 crossref_primary_10_1080_14686996_2024_2345041 crossref_primary_10_3892_ijo_2017_4202 crossref_primary_10_1007_s10735_020_09877_6 crossref_primary_10_3389_fbioe_2022_1097074 crossref_primary_10_1111_cas_13581 crossref_primary_10_1186_s10020_023_00731_5 crossref_primary_10_1016_j_phrs_2020_105278 crossref_primary_10_1109_JPHOT_2025_3571811 crossref_primary_10_3389_fpsyt_2020_00773 crossref_primary_10_3402_jev_v4_27066 crossref_primary_10_1192_j_eurpsy_2022_2319 crossref_primary_10_1186_s12974_019_1617_y crossref_primary_10_1038_s41598_019_40215_3 crossref_primary_10_1002_cyto_a_22795 crossref_primary_10_1089_neu_2017_5515 crossref_primary_10_3390_pharmaceutics15010220 crossref_primary_10_1016_j_lfs_2020_118042 crossref_primary_10_1016_j_arr_2024_102359 crossref_primary_10_1186_s12951_025_03102_w crossref_primary_10_1371_journal_pone_0089366 crossref_primary_10_1007_s13205_023_03521_2 crossref_primary_10_1016_j_pneurobio_2019_01_005 crossref_primary_10_1097_QAD_0000000000001595 crossref_primary_10_1371_journal_pone_0262884 crossref_primary_10_3390_pharmaceutics13091405 crossref_primary_10_3389_fnins_2017_00026 crossref_primary_10_1007_s40572_017_0130_7 crossref_primary_10_3389_fnagi_2025_1496252 crossref_primary_10_1371_journal_pone_0078115 crossref_primary_10_1002_glia_23445 crossref_primary_10_3390_cells12131763 crossref_primary_10_1016_j_fertnstert_2016_06_030 crossref_primary_10_1016_j_nbd_2023_106213 crossref_primary_10_1016_j_jneuroim_2023_578064 crossref_primary_10_1186_1756_6606_6_47 crossref_primary_10_3389_fcimb_2020_00099 crossref_primary_10_3390_proteomes7020017 crossref_primary_10_1016_j_addr_2023_114974 crossref_primary_10_3402_jev_v4_26316 crossref_primary_10_2147_IJN_S458397 crossref_primary_10_3389_fonc_2022_790916 crossref_primary_10_3390_ijms22084085 crossref_primary_10_3390_mi9120634 crossref_primary_10_3892_or_2015_4507 crossref_primary_10_3389_fbioe_2022_1019821 crossref_primary_10_1016_j_semcdb_2015_02_007 |
| Cites_doi | 10.1016/j.neurobiolaging.2004.04.008 10.1096/fj.08-122184 10.1186/1479-5876-9-86 10.1111/j.1601-0825.2009.01604.x 10.1016/j.vetimm.2008.04.002 10.1038/ki.2010.262 10.1073/pnas.0403453101 10.1186/gb-2006-7-8-r72 10.1016/j.ygyno.2007.08.064 10.1371/journal.pone.0008577 10.1016/j.mcn.2010.11.004 10.1073/pnas.0307981100 10.1002/path.2145 10.1034/j.1600-0854.2002.30502.x 10.1186/1743-8454-6-10 10.1523/JNEUROSCI.6476-10.2011 10.1038/sj.ki.5000273 10.1038/nature01511 10.1002/pmic.200900351 10.1038/ncomms1285 10.1038/sj.ki.5001874 10.1073/pnas.0308413101 10.1002/prca.200800140 10.1073/pnas.0603838103 10.1109/MCSE.2007.55 10.1096/fj.07-9357com 10.1681/ASN.2008040406 10.1523/JNEUROSCI.5699-09.2010 10.1002/pmic.200700455 10.4049/jimmunol.175.4.2237 10.1038/ncb1800 10.1038/nri855 10.1038/sj.ki.5002486 10.1021/pr900925d 10.1016/0003-2697(84)90782-6 10.1038/nri2567 10.1038/nbt.1807 10.1038/ki.2008.206 10.1038/ncb1596 10.1165/rcmb.2003-0238OC 10.1113/jphysiol.2011.220277 10.1111/j.1365-2125.2009.03610.x 10.1002/(SICI)1098-2787(1998)17:1<1::AID-MAS1>3.0.CO;2-K 10.1039/B916199F 10.1016/j.mcn.2005.12.003 10.1002/pmic.200600284 |
| ContentType | Journal Article |
| Copyright | Street et al; licensee BioMed Central Ltd. 2012 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. COPYRIGHT 2012 BioMed Central Ltd. 2012 Street et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright ©2012 Street et al; licensee BioMed Central Ltd. 2012 Street et al; licensee BioMed Central Ltd. |
| Copyright_xml | – notice: Street et al; licensee BioMed Central Ltd. 2012 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: COPYRIGHT 2012 BioMed Central Ltd. – notice: 2012 Street et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: Copyright ©2012 Street et al; licensee BioMed Central Ltd. 2012 Street et al; licensee BioMed Central Ltd. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/1479-5876-10-5 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ - Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ : Directory of Open Access Journals [open access] url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: ProQuest Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1479-5876 |
| EndPage | 5 |
| ExternalDocumentID | oai_doaj_org_article_618d2f87a515436ea694bcc8d5f62a35 PMC3275480 2580894371 A279979984 22221959 10_1186_1479_5876_10_5 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United Kingdom |
| GeographicLocations_xml | – name: United Kingdom |
| GrantInformation_xml | – fundername: Biotechnology and Biological Sciences Research Council – fundername: British Heart Foundation |
| GroupedDBID | --- 0R~ 29L 2VQ 2WC 4.4 53G 5VS 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EJD ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR IPNFZ ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RIG RNS ROL RPM RSV SBL SOJ TR2 TUS UKHRP WOQ WOW XSB ~8M AAYXX AFFHD CITATION ALIPV CGR CUY CVF ECM EIF NPM 3V. 7T5 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c655t-77b700cf0d9ed7f04f7eea2ad15e35a6ad781e64be5c8b2e969e441a37f255f93 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 394 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000300347200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1479-5876 |
| IngestDate | Fri Oct 03 12:52:18 EDT 2025 Tue Nov 04 01:59:42 EST 2025 Thu Oct 02 11:26:52 EDT 2025 Sat Oct 18 23:47:12 EDT 2025 Tue Nov 11 10:16:55 EST 2025 Tue Nov 04 18:06:55 EST 2025 Mon Jul 21 06:04:49 EDT 2025 Sat Nov 29 06:00:18 EST 2025 Tue Nov 18 22:26:18 EST 2025 Sat Sep 06 07:22:31 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | proteomics Exosomes human CSF |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c655t-77b700cf0d9ed7f04f7eea2ad15e35a6ad781e64be5c8b2e969e441a37f255f93 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/618d2f87a515436ea694bcc8d5f62a35 |
| PMID | 22221959 |
| PQID | 920290735 |
| PQPubID | 43076 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_618d2f87a515436ea694bcc8d5f62a35 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3275480 proquest_miscellaneous_921140769 proquest_journals_920290735 gale_infotracmisc_A279979984 gale_infotracacademiconefile_A279979984 pubmed_primary_22221959 crossref_primary_10_1186_1479_5876_10_5 crossref_citationtrail_10_1186_1479_5876_10_5 springer_journals_10_1186_1479_5876_10_5 |
| PublicationCentury | 2000 |
| PublicationDate | 2012-01-05 |
| PublicationDateYYYYMMDD | 2012-01-05 |
| PublicationDate_xml | – month: 01 year: 2012 text: 2012-01-05 day: 05 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Journal of translational medicine |
| PublicationTitleAbbrev | J Transl Med |
| PublicationTitleAlternate | J Transl Med |
| PublicationYear | 2012 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | AG Marshall (971_CR48) 1998; 17 C Thery (971_CR1) 2002; 2 RA Sharples (971_CR18) 2008; 22 PA Gonzales (971_CR16) 2009; 20 L Rajendran (971_CR17) 2006; 103 S Runz (971_CR36) 2007; 107 JM Street (971_CR47) 2011; 69 MW Graner (971_CR5) 2009; 23 B Fevrier (971_CR24) 2004; 101 JD Hunter (971_CR34) 2007; 9 H Kokubo (971_CR19) 2005; 26 LJ Vella (971_CR25) 2007; 211 R Aebersold (971_CR28) 2003; 422 J Faure (971_CR10) 2006; 31 H Zhou (971_CR8) 2006; 70 W Stoorvogel (971_CR7) 2002; 3 Y Ogata (971_CR32) 2007; 7 MV Filatov (971_CR15) 2010 MP Bard (971_CR38) 2004; 31 S Keller (971_CR4) 2007; 72 S Saman (971_CR20) 2011 D Wessel (971_CR33) 1984; 138 H Valadi (971_CR22) 2007; 9 I Potolicchio (971_CR12) 2005; 175 C Thery (971_CR3) 2006; Chapter 3 C Thery (971_CR6) 2009; 9 G Lachenal (971_CR11) 2011; 46 W Yan (971_CR27) 2009; 3 GA de Souza (971_CR29) 2006; 7 J Skog (971_CR42) 2008; 10 S Wang (971_CR13) 2011; 31 IM Rood (971_CR45) 2010; 78 MG Harrington (971_CR14) 2009; 6 LJ Vella (971_CR26) 2008; 124 CP Paweletz (971_CR49) 2010; 9 C Chen (971_CR46) 2010; 10 H Zhou (971_CR9) 2008; 74 S Hu (971_CR30) 2006; 6 V Palanisamy (971_CR39) 2010; 5 A Michael (971_CR40) 2010; 16 M Mittelbrunn (971_CR43) 2011; 2 971_CR37 S Mathivanan (971_CR41) 2009; 9 E Emmanouilidou (971_CR21) 2010; 30 L Alvarez-Erviti (971_CR44) 2011; 29 T Pisitkun (971_CR2) 2004; 101 H Zhou (971_CR31) 2006; 69 JM Street (971_CR23) 2011; 589 FI Hawari (971_CR35) 2004; 101 20052414 - PLoS One. 2010;5(1):e8577 17486113 - Nat Cell Biol. 2007 Jun;9(6):654-9 21395053 - Klin Lab Diagn. 2010 Dec;(12):35-43 17334982 - J Pathol. 2007 Apr;211(5):582-90 22025668 - J Physiol. 2011 Dec 15;589(Pt 24):6119-27 18509321 - Kidney Int. 2008 Sep;74(5):613-21 20484626 - J Neurosci. 2010 May 19;30(20):6838-51 21505438 - Nat Commun. 2011;2:282 6731838 - Anal Biochem. 1984 Apr;138(1):141-3 17021608 - Kidney Int. 2006 Nov;70(10):1847-57 19011622 - Nat Cell Biol. 2008 Dec;10(12):1470-6 21423189 - Nat Biotechnol. 2011 Apr;29(4):341-5 16081791 - J Immunol. 2005 Aug 15;175(4):2237-43 17083142 - Proteomics. 2006 Dec;6(23):6326-53 19810033 - Proteomics. 2009 Nov;9(21):4997-5000 20406221 - Br J Clin Pharmacol. 2010 Apr;69(4):367-78 16837572 - Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11172-7 9768511 - Mass Spectrom Rev. 1998 Jan-Feb;17(1):1-35 14975938 - Am J Respir Cell Mol Biol. 2004 Jul;31(1):114-21 14745008 - Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1297-302 17900673 - Gynecol Oncol. 2007 Dec;107(3):563-71 18501435 - Vet Immunol Immunopathol. 2008 Aug 15;124(3-4):385-93 20686450 - Kidney Int. 2010 Oct;78(8):810-6 19898684 - Proteomics Clin Appl. 2009 Jan 1;3(1):116-134 19735572 - Cerebrospinal Fluid Res. 2009 Sep 07;6:10 19109410 - FASEB J. 2009 May;23(5):1541-57 19056867 - J Am Soc Nephrol. 2009 Feb;20(2):363-79 16446100 - Mol Cell Neurosci. 2006 Apr;31(4):642-8 22057275 - J Biol Chem. 2012 Feb 3;287(6):3842-9 12154376 - Nat Rev Immunol. 2002 Aug;2(8):569-79 17700640 - Kidney Int. 2007 Nov;72(9):1095-102 15210972 - Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9683-8 21651777 - J Transl Med. 2011;9:86 15653169 - Neurobiol Aging. 2005 Apr;26(4):409-18 19627513 - Oral Dis. 2010 Jan;16(1):34-8 12634793 - Nature. 2003 Mar 13;422(6928):198-207 20126692 - Lab Chip. 2010 Feb 21;10(4):505-11 16501490 - Kidney Int. 2006 Apr;69(8):1471-6 16901338 - Genome Biol. 2006;7(8):R72 11967126 - Traffic. 2002 May;3(5):321-30 21593312 - J Neurosci. 2011 May 18;31(20):7275-90 20095649 - J Proteome Res. 2010 Mar 5;9(3):1392-401 17853512 - Proteomics. 2007 Oct;7(20):3726-34 18228490 - Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22 21111824 - Mol Cell Neurosci. 2011 Feb;46(2):409-18 19498381 - Nat Rev Immunol. 2009 Aug;9(8):581-93 18171695 - FASEB J. 2008 May;22(5):1469-78 15326289 - Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13368-73 |
| References_xml | – volume: 26 start-page: 409 year: 2005 ident: 971_CR19 publication-title: Neurobiology of Aging doi: 10.1016/j.neurobiolaging.2004.04.008 – volume: 23 start-page: 1541 year: 2009 ident: 971_CR5 publication-title: The FASEB Journal doi: 10.1096/fj.08-122184 – ident: 971_CR37 doi: 10.1186/1479-5876-9-86 – volume: 16 start-page: 34 year: 2010 ident: 971_CR40 publication-title: Oral Dis doi: 10.1111/j.1601-0825.2009.01604.x – volume: 124 start-page: 385 year: 2008 ident: 971_CR26 publication-title: Vet Immunol Immunopathol doi: 10.1016/j.vetimm.2008.04.002 – volume: 78 start-page: 810 year: 2010 ident: 971_CR45 publication-title: Kidney Int doi: 10.1038/ki.2010.262 – volume: 101 start-page: 13368 year: 2004 ident: 971_CR2 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0403453101 – volume: 7 start-page: R72 year: 2006 ident: 971_CR29 publication-title: Genome Biol doi: 10.1186/gb-2006-7-8-r72 – volume: 107 start-page: 563 year: 2007 ident: 971_CR36 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2007.08.064 – volume: 5 start-page: e8577 year: 2010 ident: 971_CR39 publication-title: PLoS One doi: 10.1371/journal.pone.0008577 – volume: 46 start-page: 409 year: 2011 ident: 971_CR11 publication-title: Mol Cell Neurosci doi: 10.1016/j.mcn.2010.11.004 – volume: 101 start-page: 1297 year: 2004 ident: 971_CR35 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0307981100 – volume: 211 start-page: 582 year: 2007 ident: 971_CR25 publication-title: The Journal of Pathology doi: 10.1002/path.2145 – volume: Chapter 3 start-page: 22 issue: Unit 3 year: 2006 ident: 971_CR3 publication-title: Curr Protoc Cell Biol – volume: 3 start-page: 321 year: 2002 ident: 971_CR7 publication-title: Traffic doi: 10.1034/j.1600-0854.2002.30502.x – volume: 6 start-page: 10 year: 2009 ident: 971_CR14 publication-title: Cerebrospinal Fluid Res doi: 10.1186/1743-8454-6-10 – volume: 31 start-page: 7275 year: 2011 ident: 971_CR13 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.6476-10.2011 – volume: 69 start-page: 1471 year: 2006 ident: 971_CR31 publication-title: Kidney Int doi: 10.1038/sj.ki.5000273 – volume: 422 start-page: 198 year: 2003 ident: 971_CR28 publication-title: Nature doi: 10.1038/nature01511 – volume: 9 start-page: 4997 year: 2009 ident: 971_CR41 publication-title: Proteomics doi: 10.1002/pmic.200900351 – volume: 2 start-page: 282 year: 2011 ident: 971_CR43 publication-title: Nat Commun doi: 10.1038/ncomms1285 – volume: 70 start-page: 1847 year: 2006 ident: 971_CR8 publication-title: Kidney Int doi: 10.1038/sj.ki.5001874 – volume: 101 start-page: 9683 year: 2004 ident: 971_CR24 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0308413101 – volume: 3 start-page: 116 year: 2009 ident: 971_CR27 publication-title: Proteomics Clin Appl doi: 10.1002/prca.200800140 – volume: 103 start-page: 11172 year: 2006 ident: 971_CR17 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0603838103 – volume: 9 start-page: 90 year: 2007 ident: 971_CR34 publication-title: Computing in Science & Engineering doi: 10.1109/MCSE.2007.55 – start-page: 35 volume-title: Klin Lab Diagn year: 2010 ident: 971_CR15 – volume: 22 start-page: 1469 year: 2008 ident: 971_CR18 publication-title: The FASEB Journal doi: 10.1096/fj.07-9357com – volume: 20 start-page: 363 year: 2009 ident: 971_CR16 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2008040406 – volume: 30 start-page: 6838 year: 2010 ident: 971_CR21 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5699-09.2010 – volume: 7 start-page: 3726 year: 2007 ident: 971_CR32 publication-title: Proteomics doi: 10.1002/pmic.200700455 – volume: 175 start-page: 2237 year: 2005 ident: 971_CR12 publication-title: J Immunol doi: 10.4049/jimmunol.175.4.2237 – volume: 10 start-page: 1470 year: 2008 ident: 971_CR42 publication-title: Nat Cell Biol doi: 10.1038/ncb1800 – volume: 2 start-page: 569 year: 2002 ident: 971_CR1 publication-title: Nat Rev Immunol doi: 10.1038/nri855 – volume: 72 start-page: 1095 year: 2007 ident: 971_CR4 publication-title: Kidney Int doi: 10.1038/sj.ki.5002486 – volume: 9 start-page: 1392 year: 2010 ident: 971_CR49 publication-title: J Proteome Res doi: 10.1021/pr900925d – volume: 138 start-page: 141 year: 1984 ident: 971_CR33 publication-title: Anal Biochem doi: 10.1016/0003-2697(84)90782-6 – volume-title: J Biol Chem year: 2011 ident: 971_CR20 – volume: 9 start-page: 581 year: 2009 ident: 971_CR6 publication-title: Nat Rev Immunol doi: 10.1038/nri2567 – volume: 29 start-page: 341 year: 2011 ident: 971_CR44 publication-title: Nat Biotechnol doi: 10.1038/nbt.1807 – volume: 74 start-page: 613 year: 2008 ident: 971_CR9 publication-title: Kidney Int doi: 10.1038/ki.2008.206 – volume: 9 start-page: 654 year: 2007 ident: 971_CR22 publication-title: Nat Cell Biol doi: 10.1038/ncb1596 – volume: 31 start-page: 114 year: 2004 ident: 971_CR38 publication-title: Am J Respir Cell Mol Biol doi: 10.1165/rcmb.2003-0238OC – volume: 589 start-page: 6119 year: 2011 ident: 971_CR23 publication-title: J Physiol doi: 10.1113/jphysiol.2011.220277 – volume: 69 start-page: 367 year: 2011 ident: 971_CR47 publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2009.03610.x – volume: 17 start-page: 1 year: 1998 ident: 971_CR48 publication-title: Mass Spectrom Rev doi: 10.1002/(SICI)1098-2787(1998)17:1<1::AID-MAS1>3.0.CO;2-K – volume: 10 start-page: 505 year: 2010 ident: 971_CR46 publication-title: Lab Chip doi: 10.1039/B916199F – volume: 31 start-page: 642 year: 2006 ident: 971_CR10 publication-title: Mol Cell Neurosci doi: 10.1016/j.mcn.2005.12.003 – volume: 6 start-page: 6326 year: 2006 ident: 971_CR30 publication-title: Proteomics doi: 10.1002/pmic.200600284 – reference: 20126692 - Lab Chip. 2010 Feb 21;10(4):505-11 – reference: 19627513 - Oral Dis. 2010 Jan;16(1):34-8 – reference: 11967126 - Traffic. 2002 May;3(5):321-30 – reference: 15326289 - Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13368-73 – reference: 21423189 - Nat Biotechnol. 2011 Apr;29(4):341-5 – reference: 19011622 - Nat Cell Biol. 2008 Dec;10(12):1470-6 – reference: 17334982 - J Pathol. 2007 Apr;211(5):582-90 – reference: 14975938 - Am J Respir Cell Mol Biol. 2004 Jul;31(1):114-21 – reference: 19109410 - FASEB J. 2009 May;23(5):1541-57 – reference: 21593312 - J Neurosci. 2011 May 18;31(20):7275-90 – reference: 20686450 - Kidney Int. 2010 Oct;78(8):810-6 – reference: 18228490 - Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22 – reference: 6731838 - Anal Biochem. 1984 Apr;138(1):141-3 – reference: 19498381 - Nat Rev Immunol. 2009 Aug;9(8):581-93 – reference: 21505438 - Nat Commun. 2011;2:282 – reference: 9768511 - Mass Spectrom Rev. 1998 Jan-Feb;17(1):1-35 – reference: 17021608 - Kidney Int. 2006 Nov;70(10):1847-57 – reference: 18509321 - Kidney Int. 2008 Sep;74(5):613-21 – reference: 19810033 - Proteomics. 2009 Nov;9(21):4997-5000 – reference: 15653169 - Neurobiol Aging. 2005 Apr;26(4):409-18 – reference: 21651777 - J Transl Med. 2011;9:86 – reference: 21395053 - Klin Lab Diagn. 2010 Dec;(12):35-43 – reference: 17700640 - Kidney Int. 2007 Nov;72(9):1095-102 – reference: 12154376 - Nat Rev Immunol. 2002 Aug;2(8):569-79 – reference: 17486113 - Nat Cell Biol. 2007 Jun;9(6):654-9 – reference: 21111824 - Mol Cell Neurosci. 2011 Feb;46(2):409-18 – reference: 16081791 - J Immunol. 2005 Aug 15;175(4):2237-43 – reference: 16901338 - Genome Biol. 2006;7(8):R72 – reference: 16501490 - Kidney Int. 2006 Apr;69(8):1471-6 – reference: 17083142 - Proteomics. 2006 Dec;6(23):6326-53 – reference: 18501435 - Vet Immunol Immunopathol. 2008 Aug 15;124(3-4):385-93 – reference: 20484626 - J Neurosci. 2010 May 19;30(20):6838-51 – reference: 20052414 - PLoS One. 2010;5(1):e8577 – reference: 14745008 - Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1297-302 – reference: 18171695 - FASEB J. 2008 May;22(5):1469-78 – reference: 17900673 - Gynecol Oncol. 2007 Dec;107(3):563-71 – reference: 20095649 - J Proteome Res. 2010 Mar 5;9(3):1392-401 – reference: 22057275 - J Biol Chem. 2012 Feb 3;287(6):3842-9 – reference: 19898684 - Proteomics Clin Appl. 2009 Jan 1;3(1):116-134 – reference: 12634793 - Nature. 2003 Mar 13;422(6928):198-207 – reference: 20406221 - Br J Clin Pharmacol. 2010 Apr;69(4):367-78 – reference: 16446100 - Mol Cell Neurosci. 2006 Apr;31(4):642-8 – reference: 15210972 - Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9683-8 – reference: 17853512 - Proteomics. 2007 Oct;7(20):3726-34 – reference: 19056867 - J Am Soc Nephrol. 2009 Feb;20(2):363-79 – reference: 22025668 - J Physiol. 2011 Dec 15;589(Pt 24):6119-27 – reference: 16837572 - Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11172-7 – reference: 19735572 - Cerebrospinal Fluid Res. 2009 Sep 07;6:10 |
| SSID | ssj0024549 |
| Score | 2.5077615 |
| Snippet | Background
Exosomes are released from multiple cell types, contain protein and RNA species, and have been exploited as a novel reservoir for disease biomarker... Exosomes are released from multiple cell types, contain protein and RNA species, and have been exploited as a novel reservoir for disease biomarker discovery.... Background Exosomes are released from multiple cell types, contain protein and RNA species, and have been exploited as a novel reservoir for disease biomarker... Abstract Background: Exosomes are released from multiple cell types, contain protein and RNA species, and have been exploited as a novel reservoir for disease... Abstract Background Exosomes are released from multiple cell types, contain protein and RNA species, and have been exploited as a novel reservoir for disease... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 5 |
| SubjectTerms | Aged Alzheimer's disease Biological markers Biomarkers Biomedical and Life Sciences Biomedicine Cellular proteins Cerebrospinal fluid Cerebrospinal Fluid - metabolism CSF Cyclotrons Demography Exosomes Exosomes - metabolism Exosomes - ultrastructure Fluorides Fourier Analysis Fourier transforms human Humans Ions Male Mass Spectrometry Medicine/Public Health Molecular weight Neuroscience Physiological aspects Proteins proteomics Proteomics - methods Studies Ultracentrifugation |
| SummonAdditionalLinks | – databaseName: ProQuest Publicly Available Content Database dbid: PIMPY link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB7BFiEuvB-hBfmABJdoEzt-nVBBVHBo2QNI5RQ5fsBKJSmbXcTPx5N4t6Q8TlztiTyOx-MZP74P4JkuVYNLa-5DyfKqamyuMZATvCm9VTK44AayCXlyok5P9SLRAfXpWuXWJw6OekR7xnvb0QnPXWdxx3yuY84e0zrGX55_y5FCCo9aE5_GVdhD3C01g73Fu-PFpwvovZgLJdzGUol5WUmd8-gN0BXxybo0wPf_7qR_WaUu36C8dIw6rE5Ht_5rv27DzRSkksPRqu7AFd_ehevH6Rj-Hrwfn_eGtN9HTOvIAPiAT5zJSAMe1SRdIP5H13dffU-WLRn4AIn1q5iHI10JthHONkt3Hz4evfnw-m2emBlyKzhfx5C8kUVhQ-G0dzIUVZDeG2pcyT3jRhgnVelF1XhuVUO9FtrHuMswGWIKEzR7ALO2a_0jIFY5xwpHqWtCZSxvvGKskk3lqbeSuQzy7bjUNsGWI3vGWT2kL0rUOI41jiOW8Aye7-TPR8COv0q-wmHeSSHQ9lDQrT7Xad7WolSOBiVNjPsqJrwROtpzVJoHQQ3D5tBIanQHUS1r0quG2DkE1qoPqdR4cqqqDA4mknEa20n1_tY-6uRG-npnDhmQXS1-iDfjWt9tUCRmtIUUOoOHo03uOhRDP4rYQRnIibVOejytaZdfBohxRiUCAWbwYmvXF0r9-W8-_qf--3AjRpp02LviBzBbrzb-CVyz39fLfvU0TdSfuu9OlA priority: 102 providerName: ProQuest – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Jb9UwELZKQagXdmhoQT4gwSUisePtWBAVFwpiU2-WY4_hSSVBb0H8fDxO8kpakOAaj2V7MquXbwh5YmrdomstIda8bJrWlwYDOSnaGrxWMcSQi02okxN9emre7ZBqeguTb7tPR5LZUme11vJ53ShTiqS8aDnEFXI1uTqNqvj-w-dzdL2U7ozQjJf7zFxPRui_bId_c0QXL0leOCnNDuj45v9P_Ra5MQab9GiQjttkB7o75Pqb8Tj9Lnk7PNON474ddV2gGbgBnyrToZx3Gof2kcLPftV_gxVddDTX9aMelimfxrIjOEY82yzCPfLp-NXHl6_LscJC6aUQ6xRat6qqfKyCgaBi1UQF4JgLtQAunHRB6Rpk04LwumVgpIEUPzmuYkpFouH3yW7Xd7BPqNch8CowFtrYOC9a0Jw3qm2AgVc8FKScmG_9CD-OVTDObE5DtLTIJYtcwi-iIE-39N8H4I2_Ur7Af7mlQsDs_KFffrGj_llZ68CiVi7Fbw2X4KRJcpkmLaJkjuNwKAkW1TpNy7vxdUJaHAJk2SOmDJ6A6qYghzPKpI5-1nwwyZIdzcHKGlYxk4xpGoZuW7Ej3nDroN8gScpMKyVNQR4MgrddUArhGGIAFUTNRHK24nlLt_iaocI5UwjoV5Bnk2CeT-rP3Hz476QHZC-FjyxvSIlDsrtebuARueZ_rBer5eOsmL8AC3I1XA priority: 102 providerName: Springer Nature |
| Title | Identification and proteomic profiling of exosomes in human cerebrospinal fluid |
| URI | https://link.springer.com/article/10.1186/1479-5876-10-5 https://www.ncbi.nlm.nih.gov/pubmed/22221959 https://www.proquest.com/docview/920290735 https://www.proquest.com/docview/921140769 https://pubmed.ncbi.nlm.nih.gov/PMC3275480 https://doaj.org/article/618d2f87a515436ea694bcc8d5f62a35 |
| Volume | 10 |
| WOSCitedRecordID | wos000300347200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMedCentral customDbUrl: eissn: 1479-5876 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0024549 issn: 1479-5876 databaseCode: RBZ dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ : Directory of Open Access Journals [open access] customDbUrl: eissn: 1479-5876 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0024549 issn: 1479-5876 databaseCode: DOA dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1479-5876 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0024549 issn: 1479-5876 databaseCode: M~E dateStart: 20030101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1479-5876 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0024549 issn: 1479-5876 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1479-5876 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0024549 issn: 1479-5876 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 1479-5876 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0024549 issn: 1479-5876 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1479-5876 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0024549 issn: 1479-5876 databaseCode: RSV dateStart: 20030601 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagIMQF8Sa0rHxAgkvUxI5fxxa1gkOXVXloOUWOH-pKJUH7QPx8Zpzs0hQQFy6RYk_ieDLjmfHjG0JemlI3aFrzEEueV1XjcoOOnBRNGZxW0Uefkk2o6VTP52Z2JdUX7gnr4YF7xh3KUnsWtbJgeCsug5UGXui0F1EyyxN6KXg922Bqi7InkuNbVsrkAhR-gGsstTzcleEIJEbmKKH2_z42XzFO1zdOXls9TUbp9D65N3iT9KjvxQNyI7QPyZ2zYb38EXnfn8ONw8Qcta2nCZkBzyLTPl83vJh2kYYf3ar7GlZ00dKUuI-6sISAGfOKYBvxcrPwj8mn05OPb97mQwqF3Ekh1uA7N6ooXCy8CV7FoooqBMusL0XgwkrrlS6DrJognG5YMNIEcJAsVxFijWj4E7LXdm14Riiw3PPCM-abWFknmqA5r1RTBRac4j4j-ZaTtRvwxTHNxWWd4gwta-R8jZzHEpGRVzv6bz2yxl8pj_HH7KgQETsVgJzUg5zU_5ITaA5_a416C5_l7HD8ADqHCFj1EVMGlzh1lZGDESXomxtV728Fox70fVUbVjADoyU0Q3e1-CBuYWtDt0ESCD0LJU1GnvZStOsQ-GgMQX4yokbyNerxuKZdXCQscM4UIvZl5PVWEn991J-5-fx_cHOf3AXPkaW5KHFA9tbLTXhBbrvv68VqOSE31Vylq56QW8cn09n5JOkn3M3enc2-wN35h88_AfsQPBg |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9UwELaqgqAX9pbQAj6A4BI1ceIlB4TKUrVq--BQpHcLjj2GJ5WkvIXlR_Ef8TjJKynLrQeusaPYzsw3M_b4G0IeFamq0LTG4NIszvPKxAU6coJXKRglnXU2FJuQo5Eaj4u3K-RHfxcG0yp7TAxAbRuDe-TbhY_SfSCX8eenn2MsGoWHq30FjVYqDuD7Vx-xzZ7tv_K_9zFju6-PX-7FXVGB2AjO596brGSSGJfYAqx0Se4kgGbaphwyroW2UqUg8gq4URWDQhTgXQadSee9b4fcSx7xL3kYl5hBJsdn8V3uY62OFzJVYjvNZRFzjzYIdXxg90J5gN-NwC9W8HyG5rlj2mD9dq__Z-t2g1zr3Gy60-rFTbIC9S1y5ahLJLhN3rQXlF23Y0l1bWmgrMBL2rQtZO4XgjaOwrdm1nyCGZ3UNFQ0pAamUE2x4Ap-w50sJvYOeXch01knq3VTw11CjbI2SyxjtnK5NrwClWW5rHJgYGRmIxL3f740HfE61v84KUMApkSJklKipOATHpEny_6nLeXIX3u-QEFa9kKq8PCgmX4oO-QpRaosc0pq77nmmQAtCq-RftDcCaYz_ByKYYmA5odldHcvw08OqcHKHSYLPPtVeUS2Bj09EJlB82YvgWUHhLNyKX4RoctWfBFz-2poFtjFx-SJFEVENlqpX07IO68M2Y8iIgf6MJjxsKWefAwk6RmTSGUYkae95pwN6s-ree-f439Iru4dHx2Wh_ujg02y5v1mFnbi-BZZnU8XcJ9cNl_mk9n0QQAFSt5ftDb9BIl9oB8 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9UwELZKQRUX9kJoAR-Q4BI18W6JS1meQMCjEot6sxwv8KSSVG9B_Hw8Tt4raUFC4mqP5W3GnvF4vkHosa5VA1drGWJNS8YaV2pQ5ARv6uCUjD76nGxCTqfq-FgfbaFn61iY_Nt97ZLsYxoApaldHpz62Iu4Egc1k7rkSZDhFOGX0GUGCYPAVv_45QxpL5k-A0zjxTajayij9V88k3-7lM5_mDznNc2X0eT6_03jBro2KKH4sOeam2grtLfQzvvBzX4bfejDd-Pwnodt63EGdIAQZtyn-U594i7i8LNbdN_DAs9anPP9YRfmyc6GdCTQRzxZzfwd9Hny6tOL1-WQeaF0gvNlUrkbWVUuVl4HL2PFogzBEutrHii3wnqp6iBYE7hTDQla6JD0KktlTCZK1HQXbbddG-4h7JT3tPKE-CYy63gTFKVMNiyQ4CT1BSrXG2HcAEsO2TFOTDZPlDCwSgZWCUp4gZ5s6E97QI6_Uj6Hfd1QAZB2LujmX80gl0bUypOopE16HaMiWKETv6ZB8yiIpdAdcIUBcU_DcnaIWkiTA-Asc0ikBs-oYgXaH1EmMXWj6r01X5nhmFgYTSqi0yGbusGbWmgIP9_a0K2AJFmslRS6QHd7JtxMKKl2BLCBCiRH7Dma8bimnX3LEOKUSAD6K9DTNZOeDerPq3n_30kfoZ2jlxPz7s307R66mjRMkt-s-D7aXs5X4QG64n4sZ4v5wyyvvwCtekEk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+and+proteomic+profiling+of+exosomes+in+human+cerebrospinal+fluid&rft.jtitle=Journal+of+translational+medicine&rft.au=Street+Jonathan+M&rft.au=Barran+Perdita+E&rft.au=Mackay+C+Logan&rft.au=Weidt+Stefan&rft.date=2012-01-05&rft.pub=BMC&rft.issn=1479-5876&rft.eissn=1479-5876&rft.volume=10&rft.issue=1&rft.spage=5&rft_id=info:doi/10.1186%2F1479-5876-10-5&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_618d2f87a515436ea694bcc8d5f62a35 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-5876&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-5876&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-5876&client=summon |